Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10Colonic Neoplasms 9Prostatic Neoplasms 8Colorectal Neoplasms 6Neoplasms 5Multiple Myeloma 4Uterine Cervical Neoplasms 3Stomach Neoplasms 3Smoldering Multiple Myeloma 3Rectal Neoplasms 3Pancreatic Neoplasms 3Monoclonal Gammopathy of Undetermined Significance 3Lung Neoplasms 3Adenomatous Polyposis Coli 3Uterine Cervical Dysplasia 2Radiodermatitis 2Pain 2Esophageal Neoplasms 2Breast Carcinoma In Situ 2cyclopia sequence 1Uterine Neoplasms 1Tuberous Sclerosis 1Thrombocythemia, Essential 1Stomatitis 1Sezary Syndrome 1Seizures 1Psychological Well-Being 1Prostate Cancer Metastatic Castration Resistant 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cisplatin 55Carboplatin 50pembrolizumab 42Paclitaxel 42Gemcitabine 28Pemetrexed 23Radiotherapy 21Magnetic Resonance Spectroscopy 20Radiotherapy, Intensity-Modulated 18Docetaxel 17Cetuximab 17Specimen Handling 16Nivolumab 16Fluorouracil 16Cyclophosphamide 14durvalumab 13Bevacizumab 12Radiation 11130-nm albumin-bound paclitaxel 11Sorafenib 10Platinum 101,2-diaminocyclohexaneplatinum II citrate 10osimertinib 9Sunitinib 8Oxaliplatin 8Irinotecan 8Ipilimumab 8Everolimus 8Drug Therapy 8Capecitabine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma × Curcumin × Clear all
NCT00192842 2010-09-22

Gemcitabine With Curcumin for Pancreatic Cancer

Rambam Health Care Campus

Phase 2 Completed
17 enrolled
Gastrointestinal

Carcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡